Medical Dosimetry
Volume 34, Issue 1 , Pages 30-35 , Spring 2009

Variability of Gross Tumor Volume Delineation in Head-and-Neck Cancer Using PET/CT Fusion, Part II: The Impact of a Contouring Protocol

Received 18 July 2007 ,Accepted 28 July 2007.

References 

  1. Kinahan PE, Townsend DW, Beyer T, et al. Attenuation correction for a combined 3D PET/CT scanner. Med. Phys. 1998;25:2046–2053
  2. Wang D, Schultz CJ, Jursinic PA, et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2006;1:143–151
  3. Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck. 2005;27:478–487
  4. Scarfone C, Lavely W, Cmelak A, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J. Nucl. Med. 2004;45:542–552
  5. Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 2002;53:1051–1057
  6. Schöder H, Yeung HWD, Gonen M, et al. Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65–72
  7. Heron DE, Andrade RS, Flickinger J, et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int. J. Radiat. Oncol. Biol. Phys. 2004;60:1419–1424
  8. Ciernik F, Dizendorf E, Baumert B, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int. J. Radiat. Oncol. Biol. Phys. 2003;57:853–863
  9. Caldwell C, Mah K, Ung Y, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion. Int. J. Radiat. Oncol. Biol. Phys. 2001;51:923–931
  10. Syed R, Bomanji JB, Nagabhushan N, et al. Impact of combined (18)F-FDG PET/CT in head and neck tumours. Br. J. Cancer. 2005;92:1046–1050
  11. Riegel AC, Berson AM, Destian S, et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:726–732
  12. Weiss E, Hess CF. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy. Strahlenther. Onkol. 2003;1:21–30
  13. Giraud P, Elles S, Helfre S, et al. Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother. Oncol. 2002;62:27–36
  14. Coles CE, Hoole ACF, Harden SV, et al. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: Quality assurance for the SIOP PNET 4 trial protocol. Radiother. Oncol. 2003;60:189–194
  15. Bowden P, Fisher R, MacManus M, et al. Measurement of lung tumor volumes using three-dimensional computer planning software. Int. J. Radiat. Oncol. Biol. Phys. 2003;3:566–573
  16. Senan S, van Sörnsen de Koste J, Samson M, et al. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother. Oncol. 1999;53:247–255
  17. Oshida M, Uno K, Suzuki M, et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-Deoxy-2-Fluoro[18F]-D-Glucose. Cancer. 1998;82:2227–2234
  18. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions. Radiology. 2001;219:774–777
  19. Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J. Nucl. Med. 2005;46:1342–1348
  20. Paulino AC, Johnstone PA. FDG-PET in radiotherapy treatment planning: Pandora's box?. Int. J. Radiat. Oncol. Biol. Phys. 2004;59:4–5
  21. International Commission on Radiation Units and Measurements. 1993 ICRU Report 50: Prescribing, Recording and Reporting Photon Beam Therapy. Bethesda: ICRU; 1993;
  22. Lowry R. Vassar Stats: Web Site for Statistical Computation. Vassar College. http://faculty.vassar.edu/lowry/VassarStats.htmlAccessed December 21, 2005
  23. Jones D, Hafermann MD, Rieke JW, et al. An estimate of the margin required when defining blocks around the prostate. Br. J. Radiol. 1995;68:740–746
  24. Van de Steene J, Linthout N, de Mey J, et al. Definition of gross tumor volume in lung cancer: Inter-observer variability. Radiother. Oncol. 2002;62:37–49
  25. Logue JP, Sharrock CL, Cowan RA, et al. Clinical variability of target volume description in conformal radiotherapy planning. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:929–931
  26. Pitkänen MA, Holli KA, Ojala AT, et al. Quality assurance of radiotherapy of breast cancer: Variability in planning target volume definition. Acta. Oncol. 2001;40:50–55
  27. Steenbakkers RJH, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:435–448
  28. Steenbakkers RJH, Duppen JC, Fitton I, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: A ‘Big Brother’ evaluation. Radiother. Oncol. 2005;77:182–190
  29. van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat. Rev. 2006;32:245–260
  30. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolarygneal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology. 2004;233:93–100
  31. Tai P, Van Dyk J, Yu E, et al. Variability of target volume delineation in cervical esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:277–288
  32. Schöder H, Yeung HWD, Larson SM. CT in PET/CT: Essential features of interpretation. J. Nucl. Med. 2005;46:1249–1251
  33. Coleman RE, Delbeke D, Guiberteau MJ, et al. Concurrent PET/CT with an integrated imaging system: Intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J. Nucl. Med. 2005;46:1225–1239
  34. Weiss E, Richter S, Krauss T, et al. Conformal radiotherapy planning of cervix carcinoma: Differences in the delineation of the clinical target volume (A comparison between gynaecologic and radiation oncologists). Radiother. Oncol. 2003;67:87–95
  35. Leunens G, Menten J, Weltens C, et al. Quality assessment of medical decision making in radiation oncology: Variability in target volume delineation for brain tumours. Radiother. Oncol. 1993;29:169–175
  36. Hurkmans CW, Borger JH, Pieters BR, et al. Variability in target volume delineation on CT scans of the breast. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:1366–1372
  37. Geets X, Daisne JF, Tomsej M, et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies. Radiother. Oncol. 2006;78:291–297
  38. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 1997;39:841–848

 The abstract of this study was accepted for poster display at ASTRO 2006 in Philadelphia, November 5–9, 2006.

PII: S0958-3947(07)00156-2

doi: 10.1016/j.meddos.2007.08.003

Medical Dosimetry
Volume 34, Issue 1 , Pages 30-35 , Spring 2009

Article Tools

* Image Usage & Resolution